Source: NASDAQ Stocks / 26 Oct 2024 11:01:56 America/New_York
Fintel reports that on October 25, 2024, Jefferies downgraded their outlook for Marinus Pharmaceuticals (LSE:0JYL) from Buy to Hold.
https://www.nasdaq.com/articles/jefferies-downgrades-marinus-pharmaceuticals-lse-0jyl